Ophthalmic Viscosurgical Devices Market Size, Share, Growth, and Industry Analysis, By Type (dispersive, cohesive & combined), by application, (hospitals, clinics & others), and Regional Insights and Forecast to 2034

•   
•   
  

  Request a Free sample to learn more about this report

    

OPHTHALMIC VISCOSURGICAL DEVICES MARKET OVERVIEW

The global ophthalmic viscosurgical devices market size was USD 2.1500 billion in 2025 and is projected to touch USD 0.2640 billion by 2034, exhibiting a CAGR of –18.42% during the forecast period.

The ophthalmic viscosurgical devices (OVD) industry is a critical factor in the contemporary eye surgery, especially cataract, glaucoma, and cornea operations. The OVDs play a vital role in ensuring the space inside the anterior chamber is preserved, ocular tissues are safeguarded and that surgical accuracy is increased during the delicate procedures on the eye. The market is motivated by the growing number of eye disorders associated with age, technological improvement in the field of surgery, and the surge in the need of a minimally invasive surgery. Market growth is also being driven by increasing awareness of vision health, increasing numbers of cataract surgeries as well as the availability of the high-technology healthcare systems across the world. Large manufacturers are trying to design biocompatible, high-performance ocular isomers to enhance the safety and postoperative outcome. As the applications of OVDs keep on growing with a continuous innovation, the OVD market is projected to be growing steadily in the next few years.

COVID-19 IMPACT

Pandemic hindered the market growth due to hospitals and clinics focused on emergency care thus reducing the volume of surgery

The COVID-19 impact the ophthalmic viscosurgical devices market growth, which was mostly caused by the fact that elective eye surgery, such as cataract and glaucoma surgeries, was suspended. Hospitals and clinics focused on emergency care thus reducing the volume of surgery and demand of OVDs. Interruptions in the supply chains also had an influence on the production and distribution in regions. Nonetheless, with the relaxation of restrictions, the market experienced a powerful recovery as a result of the reinstatement of postponed surgeries and increased awareness of patients on the health of their vision. Other urgent needs during the pandemic that were expedited in the intake of digital health technologies, tele ophthalmology, and improved infection control in surgical departments. Amidst the post-pandemic period, the steady growth in the market is projected to occur as the investments in healthcare increase, the effective patient flow management, and the restored emphasis on the preventive eye care.

LATEST TRENDS

Creation of biocompatible and viscoadaptive OVDs to be prominent trends

Ophthalmic Viscosurgical Devices market is growing very well due to the development of cataract and refractive surgery technology. One of the trends is the creation of biocompatible and viscoadaptive OVDs, which increases the accuracy of surgical operations and patient recovery. The growth in the popularity of combination OVDs with cohesive and dispersive qualities enhances intraocular stability and makes surgery easier. The low-viscosity and easy-injection formulations are gaining demand through the promotion done by minimally invasive cataract surgeries (MICS). Furthermore, the fact that premium intraocular lenses (IOLs) and robotics have been integrated enhances the utilization of high-performance OVDs. Other emerging areas of focus include sustainability and cost efficiency where manufacturers are focusing on single-use products, sterile products, and products that are friendly to the environment. The increasing cases of eye disorders with aging population in the world keeps on driving market growth.

•   
•   
  

  Request a Free sample to learn more about this report

    

OPHTHALMIC VISCOSURGICAL DEVICES MARKET SEGMENTATION

By Type

Based on type, the global market can be categorized into dispersive, cohesive & combined.

• Dispersive: Dispersive ophthalmic viscosurgical equipment offers superb coating and safeguard to the ocular tissues during the operation. They preserve the safety of corneal endothelium and provide the extended retention of the anterior chamber.

• Cohesive: Cohesive OVDs are very viscous that makes them perfect in preserving the depth and space formation of the anterior chamber during surgery. They are simple to extract, reduces the postoperative problems and enhances the performance of surgery.

• Combined: ODVDs combine or viscoadaptive properties, which guarantee maximum protection of the tissues with stability in the chamber. They are accustomed to operating situations, making it easier and more effective to have cataract and intraocular lenses.

By Application

Based on application, the global market can be categorized into hospitals, clinics & others.

• Hospitals: The largest end-users of ophthalmic viscosurgical equipment are the hospitals, which carry out complicated cataract surgery and refractive surgery. They have the best eye care infrastructure, trained surgeons, and they purchase high quality and volume of OVDs to ensure maximum results.

• Clinics: Ophthalmic viscosurgical devices are also being used in clinics to do outpatient cataract and minor eye operations. Their increasing inclination toward cost effective and minimally invasive procedures generates a constant need among them to use small and efficient OVD solutions.

• Others: Ambulatory surgical centres and specialized ophthalmic institute are other end-users. The focus of these facilities is fast and highly accurate procedures, which focus on the use of advanced OVDs to boost patient comfort, minimize the surgical time, and boost a visual recovery rate.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factors

Cases of cataract and glaucoma to increase the market growth

One of the greatest forces behind the Ophthalmic Viscosurgical Devices (OVD) market is the increasing cases of cataract and glaucoma in most parts of the world particularly to the ageing group. With the population becoming old globally, cases of age related eye diseases such as cataracts, which is the clouding of the lens, and also glaucoma which is the destruction of the optic nerves are on the rise. This has drastically increased the need of ophthalmic surgeries, especially cataract removal, and implanting the intraocular lenses. OVDs are very important during such procedures, as they will hold the anterior chamber, safeguard ocular tissues and proper placement of the lens. The increased availability of high-level eye care services and government programs that facilitate the restoration of vision continue to increase the volume of surgery hence increasing the demand of high-performance, safe, and efficient OVDs in both developed and emerging economies.

Use of the high-end intraocular lenses to increase the market growth

The use of the high-end intraocular lenses (IOLs) is also becoming a major contributor to the use of sophisticated Ophthalmic Viscosurgical Devices (OVDs). Multifocal and accommodating lenses are the examples of premium IOLs that provide better visual results and less reliance on correctional vision blades, and they have become especially popular in cataract and refractive surgeries. However, these high-precision glasses demand high accuracy of stability in the chambers and safety of sensitive ocular tissue upon the implementation. OVDs assure this stability by keeping the space in the anterior chamber and protecting the corneal endothelium. Doctors are more attracted to viscoadaptive and cohesive OVDs due to their better manipulation and easy extraction. As the number of patients demanding better postoperative vision and comfort increases, there is a growing use of high quality IOLs that is pushing the technological innovations and market development in the ophthalmic viscosurgical devices industry.

Restraining Factor

Limited shelf life and special storage conditions to limit the market growth

The limited shelf life and special storage conditions of some Ophthalmic Viscosurgical Device (OVD) formulations are a significant limitation to market development. Numerous OVDs, particularly those with natural polymers such as hyaluronic acid are sensitive to temperature, light and contamination. They have to be kept in controlled conditions in order to preserve viscosity, sterility, and performance. Any variation may compromise the quality of the product, and hence the decreased efficacy of the product in the surgical procedures. This sensitivity poses logistical difficulties in healthcare facilities especially in areas where there is a poor cold-chain support or variable weather. Also, the necessity to control the inventory and replace it regularly makes hospital and clinic operations more expensive. Smaller eye care facilities might also be challenged by the inability to preserve the best possible conditions of storing solutions, which narrows their possibilities to keep up with the latest OVDs being constantly available and so hinders their further implementation and distribution in the new markets.

Technological advancement and the increase in the demand of eye care across the world to opportunity in the market

Opportunity

The Ophthalmic Viscosurgical Devices market has a good future due to the technological advancement and the increase in the demand of eye care across the world. Growth in the market will increase as more people adopt minimally invasive cataract and refractive surgeries and new biocompatible and viscoadaptive OVD formulations are developed. New prospects are also generated by the increasing infrastructure of healthcare and awareness of vision correction in the new markets of India and China.

In addition, the introduction of single-use, cost-effective, and environmentally friendly OVDs will appeal to more customers. The future of ophthalmic surgery integration with robotic-assisted surgical systems should provide more accurate, efficient, and safe treatments, which will open new possibilities in ophthalmic treatment.

Issue of balancing the cost and quality could be a potential challenge

Challenge

The biggest problem facing the future ophthalmic viscosurgical devices market is the issue of balancing the cost, quality, and accessibility. The cost of the advanced OVDs and high surgical technology is too high and its use in the developing countries is restricted. The high-level of sterility and storage conditions further impose logistical and financial burdens on the healthcare providers.

In addition, poor reimbursement cover on ophthalmic surgeries limits the affordability of patients. Products standardization is also a challenge in the market since different regions have different preferences in surgery and the different laws complicate global distribution. In addition, the lack of professionals in the field of ophthalmic surgery and slower implementation of new surgical equipment can impede the regular market penetration and development across the globe.

•   
•   
  Request a Free sample to learn more about this report

    

OPHTHALMIC VISCOSURGICAL DEVICES REGIONAL INSIGHTS

• North America

The North America dominates the ophthalmic viscosurgical devices share due to the well-established healthcare facilities, the presence of influential manufacturers, and the rising cases of cataract and glaucoma. The central role is given to the United States ophthalmic viscosurgical devices share because it has a high percentage of cataract surgeries, increasing geriatric population and an early introduction to technologically advanced ophthalmic solutions. Market growth is further supported by the increasing awareness regarding eye health, positive reimbursement policies as well as solid regulatory backing. The Alcon, Johnson and Johnson Vision, and Bausch Lomb are leading companies that constantly invest in research and innovation in order to improve product safety and surgical outcomes. In addition, with increased demand of minimally invasive eye procedures and the government support of vision care in the U.S., the country makes a significant contribution to the dominance of North America in the worldwide OVD market.

• Europe

The European market is a major part of the ophthalmic viscosurgical devices industry owing to the robust healthcare system, technology in the field of ophthalmic and increased prevalence of age related eye conditions, including cataracts and glaucoma. Germany, France and the United Kingdom are major contributors with the help of rising number of cataract surgeries and sound reimbursement systems. The increasing knowledge on eye health, presence of qualified ophthalmic surgeons and implementation of minimal invasive surgical procedures are also contributing to the demand of OVDs. Besides, surgical accuracy and patient safety are improved by constant product innovation by major manufacturers in Europe and across the world. Favourable regulatory standards and healthcare modernisation investments also make the region stronger on the market. All over, the OVD market is growing due to the emphasis of high-quality eye care in Europe and the growth in the volume of surgery.

• Asia

Asia-Pacific ophthalmic viscosurgical devices market is currently under the aggressive growth due to excessive old population and the growing rate of cataracts as well as growing awareness of the advanced eye care solutions. The main contributors are the countries such as China, India and Japan, which are backed by growing healthcare facilities and government policies advocating the use of vision care. The increasing medical tourism and access to affordable surgery also increase the demand in the market. The availability of quality OVDs is increased by the availability of technology and the availability of international players who have established partnerships with domestic firms. In addition, the rise in disposable incomes and enhanced health insurance cover boosts patients to pursue complex eye surgeries. As minimally invasive surgical procedures become increasingly popular, eye care becomes more and more invested in, Asia-Pacific is likely to continue to be one of the most rapidly growing markets of ophthalmic viscosurgical equipment.

KEY INDUSTRY PLAYERS

Key Players contributes to the development of biocompatibility, surgical efficiency, and patient recovery throughout the ophthalmic viscosurgical devices market

The leading players in the Ophthalmic Viscosurgical Devices market include Carl Zeiss Meditec AG, Johnson and Johnson Vision, Pfizer Inc., Allergan plc and Hyaltech Ltd among others, which play a significant role in innovating and developing the market. Carl Zeiss Meditec is a manufacturer that has ophthalmic solutions that have been precision-based and have been known to increase the safety and visual outcome during surgery. Johnson and Johnson vision has provided high-tech OVDs that are combined with high-end intra ocular lenses used in the cataract operation. Pfizer has used its good experience in pharmaceuticals to come up with biocompatible and high-performance OVD formulations. With its long-range line of ophthalmic products, Allergan specialises in improving the eye health and accuracy in surgery. Hyaltech, which is a company that deals with hyaluronic acid, based products offers high quality of viscoelastic solutions that assure excellent stability of chambers. A combination of these companies contributes to the development of biocompatibility, surgical efficiency, and patient recovery throughout the ophthalmic viscosurgical devices market.

List Of Top Ophthalmic Viscosurgical Devices Companies

• Carl Zeiss (Germany)
• Johnson & Johnson (U.S.)
• Pfizer (U.S.)
• Allergan (Ireland)
• Hyaltech (U.K.)
• Valeant Pharmaceuticals (Canada)

KEY INDUSTRY DEVELOPMENT

June 2024: Alcon was given FDA approval of its UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS), the first of its new Unity line. This is a milestone in the growth of Alcon in the eye care market, which supports its dominance in ophthalmic innovation. The UNITY systems will improve the efficiency, accuracy, and safety of surgical practice to provide the next generation of solutions to cataract surgery and vitreoretinal surgery and thereby, raise the clinical outcomes and patient care in contemporary ophthalmology practice.

REPORT COVERAGE

This report is a historical analysis of the world Ophthalmic Viscosurgical Devices market covering the year 2018-2022 and used recent forecast estimates on the year 2023-2034. It analyses the dynamics of markets looking at them in a variety of ways such as the type of products, their use, who used the products, and developments in regions. The research provides a comprehensive information about the market dynamics, technology, competitive environment and drivers of growth and factors that affect the performance in the market. The combination of qualitative and quantitative data helped the report to make the readers perceive the evolution of the market, emerging opportunities, and possible risks. It also gives focus to strategic driven projects, such as mergers, acquisitions and product inventions by major players and this will determine the future of the OVD industry. In general, the analysis would assist the stakeholders, investors, and decision-makers to develop effective business strategies and find lucrative segments in the fast-growing global ophthalmic viscosurgical devices market.